Whether recovering from injury, managing joint discomfort, or supporting gut health, BPC-157 may help your body rebuild stronger
The compelling results indicate that the milk sEV capsules we developed have the potential to enhance the oral absorption and efficacy of both semaglutide and tirzepatide, offering promising prospects for advanced oral peptide drug delivery
In preclinical data, the pair improves adipocyte NAD+ by inhibiting NNMT, resulting in better fat metabolism and reduced obesity.[8][3] For anti-aging, this translates to improved tissue resilience and reduced senescence
These medications work by mimicking naturally occurring incretin hormones, which slow gastric emptyingthe rate at which food moves from the stomach into the small intestine
Tirzepatide, on the other hand, is a dual-acting GIP and GLP-1 receptor agonist, which means it targets both GIP and GLP-1 receptors to enhance insulin secretion and promote satiety